$4.36 Billion is the total value of Perceptive Advisors's 104 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 48.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $339,734,000 | +2.6% | 4,023,862 | +7.1% | 7.80% | -16.6% |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS INC | $303,803,000 | +3.9% | 5,775,726 | +4.5% | 6.97% | -15.5% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $298,659,000 | +249.9% | 2,899,606 | +149.0% | 6.85% | +184.6% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $292,158,000 | +151.1% | 11,915,127 | -2.6% | 6.70% | +104.2% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $268,438,000 | -8.8% | 21,509,486 | -0.6% | 6.16% | -25.8% |
| ATNX | Buy | ATHENEX INC | $187,636,000 | +200.6% | 9,822,118 | +92.7% | 4.31% | +144.5% |
| BBIO | New | BRIDGEBIO PHARMA INC | $180,868,000 | – | 6,706,268 | +100.0% | 4.15% | – |
| ZGNX | Sell | ZOGENIX INC | $167,575,000 | -21.3% | 3,507,223 | -9.4% | 3.84% | -36.0% |
| MGTX | MEIRAGTX HOLDINGS PLC | $155,766,000 | +50.5% | 6,007,746 | 0.0% | 3.57% | +22.4% | |
| AMRN | Sell | AMARIN CORPORATION PLCspons adr new | $120,242,000 | -11.5% | 6,201,269 | -5.2% | 2.76% | -28.0% |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $114,397,000 | +12.4% | 1,212,731 | -4.6% | 2.62% | -8.6% |
| QTNT | QUOTIENT LTD | $100,877,000 | +3.8% | 10,789,054 | 0.0% | 2.32% | -15.6% | |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $80,919,000 | +28.9% | 1,380,171 | -1.4% | 1.86% | +4.9% |
| RTRX | Buy | RETROPHIN INC | $75,791,000 | +9.6% | 3,772,582 | +23.5% | 1.74% | -10.8% |
| NVRO | Buy | NEVRO CORP | $73,761,000 | +183.0% | 1,137,765 | +172.9% | 1.69% | +130.3% |
| CRNX | CRINETICS PHARMACEUTICALS INC | $64,698,000 | +9.8% | 2,587,953 | 0.0% | 1.48% | -10.6% | |
| MYOK | Buy | MYOKARDIA INC | $55,180,000 | +7.4% | 1,100,511 | +11.3% | 1.27% | -12.7% |
| ALBO | ALBIREO PHARMA INC | $54,948,000 | +0.1% | 1,704,330 | 0.0% | 1.26% | -18.6% | |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $54,521,000 | -58.4% | 473,475 | -57.5% | 1.25% | -66.2% |
| ZYME | Buy | ZYMEWORKS INC | $52,115,000 | +511.0% | 2,368,890 | +312.8% | 1.20% | +396.3% |
| DOVA | Buy | DOVA PHARMACEUTICALS INC | $50,098,000 | +80.3% | 3,553,060 | +13.7% | 1.15% | +46.7% |
| RGNX | Sell | REGENXBIO INC | $49,880,000 | -24.0% | 970,997 | -15.3% | 1.14% | -38.2% |
| MMSI | Sell | MERIT MEDICAL SYSTEMS INC | $48,673,000 | -25.2% | 817,209 | -22.4% | 1.12% | -39.2% |
| ARRY | Sell | ARRAY BIOPHARMA INC | $48,109,000 | -53.3% | 1,038,390 | -75.4% | 1.10% | -62.0% |
| VRAY | Buy | VIEWRAY INC | $48,061,000 | +35.3% | 5,455,243 | +13.5% | 1.10% | +10.1% |
| ADMA | Buy | ADMA BIOLOGICS INC | $44,586,000 | +80.4% | 11,521,102 | +76.7% | 1.02% | +46.8% |
| ALLO | ALLOGENE THERAPEUTICS INC | $41,450,000 | -7.1% | 1,543,790 | 0.0% | 0.95% | -24.5% | |
| VRCA | VERRICA PHARMACEUTICALS INC | $39,628,000 | +2.8% | 3,410,412 | 0.0% | 0.91% | -16.4% | |
| KOD | KODIAK SCIENCES INC | $36,681,000 | +79.2% | 3,135,199 | 0.0% | 0.84% | +45.7% | |
| MNTA | Buy | MOMENTA PHARMACEUTICALS INC | $36,167,000 | -13.4% | 2,905,000 | +1.0% | 0.83% | -29.6% |
| ONCE | New | SPARK THERAPEUTICS INC | $35,833,000 | – | 350,000 | +100.0% | 0.82% | – |
| CTMX | Sell | CYTOMX THERAPEUTICS INC | $35,387,000 | +3.7% | 3,153,923 | -0.6% | 0.81% | -15.7% |
| EHTH | Buy | EHEALTH INC | $33,233,000 | +83.9% | 385,982 | +33.2% | 0.76% | +49.6% |
| VAPO | Buy | VAPOTHERM INC | $32,302,000 | +31.9% | 1,404,470 | +12.7% | 0.74% | +7.2% |
| NVTA | Sell | INVITAE CORP | $31,572,000 | -37.9% | 1,343,491 | -38.1% | 0.72% | -49.5% |
| NEPT | NEPTUNE WELLNESS SOLUTIONS INC | $29,978,000 | +5.7% | 8,891,452 | 0.0% | 0.69% | -14.0% | |
| RCKT | Buy | ROCKET PHARMACEUTICALS INC | $29,661,000 | +269.1% | 1,977,412 | +331.6% | 0.68% | +200.0% |
| DBVT | Buy | DBV TECHNOLOGIES S Asponsored adr | $29,666,000 | +241.0% | 3,609,084 | +219.8% | 0.68% | +178.0% |
| ESTA | Buy | ESTABLISHMENT LABS HLDGS INC | $27,719,000 | +87.7% | 1,260,528 | +105.2% | 0.64% | +52.5% |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $27,657,000 | -50.6% | 3,862,821 | -8.3% | 0.64% | -59.8% |
| KDMN | KADMON HOLDINGS INC | $27,121,000 | -22.0% | 13,165,746 | 0.0% | 0.62% | -36.6% | |
| CNCE | CONCERT PHARMACEUTICALS INC | $26,456,000 | -0.6% | 2,204,641 | 0.0% | 0.61% | -19.2% | |
| PROTAGONIST THERAPEUTICS INC | $25,083,000 | -3.7% | 2,071,297 | 0.0% | 0.58% | -21.6% | ||
| VBIV | Buy | VBI VACCINES INC | $24,607,000 | -42.3% | 25,951,556 | +8.4% | 0.56% | -53.0% |
| SLDB | New | SOLID BIOSCIENCES INC | $22,581,000 | – | 3,927,222 | +100.0% | 0.52% | – |
| QURE | Buy | UNIQURE N.V | $22,024,000 | +59.3% | 281,820 | +21.6% | 0.50% | +29.5% |
| EIDX | EIDOS THERAPEUTICS INC | $21,349,000 | +32.5% | 686,992 | 0.0% | 0.49% | +7.7% | |
| TDOC | Sell | TELADOC HEALTH INC | $20,389,000 | -25.9% | 307,021 | -38.0% | 0.47% | -39.8% |
| STOK | New | STOKE THERAPEUTICS INC | $19,601,000 | – | 671,978 | +100.0% | 0.45% | – |
| ALDX | ALDEYRA THERAPEUTICS INC | $18,512,000 | -33.6% | 3,085,458 | 0.0% | 0.42% | -45.9% | |
| TPTX | New | TURNING POINT THERAPEUTICS I | $17,296,000 | – | 424,968 | +100.0% | 0.40% | – |
| MTEM | MOLECULAR TEMPLATES INC | $16,484,000 | +43.7% | 1,974,133 | 0.0% | 0.38% | +16.7% | |
| MRKR | MARKER THERAPEUTICS INC | $15,840,000 | +20.0% | 2,000,000 | 0.0% | 0.36% | -2.4% | |
| BHC | BAUSCH HEALTH COS INC | $15,132,000 | +2.1% | 600,000 | 0.0% | 0.35% | -17.0% | |
| UROV | Buy | UROVANT SCIENCES LTD | $14,835,000 | +70.6% | 1,875,426 | +116.7% | 0.34% | +38.8% |
| ADPT | New | ADAPTIVE BIOTECHNOLOGIES COR | $13,766,000 | – | 285,000 | +100.0% | 0.32% | – |
| MORF | New | MORPHIC HOLDING INC | $12,883,000 | – | 650,000 | +100.0% | 0.30% | – |
| MOTS | Buy | MOTUS GI HLDGS INC | $12,757,000 | +1.9% | 4,210,542 | +31.1% | 0.29% | -17.0% |
| AXNX | Sell | AXONICS MODULATION TECHNOLOGIES INC | $11,697,000 | -28.8% | 285,502 | -58.4% | 0.27% | -42.1% |
| IDYA | New | IDEAYA BIOSCIENCES INC | $11,369,000 | – | 1,141,484 | +100.0% | 0.26% | – |
| FOMX | FOAMIX PHARMACEUTICALS LTD | $11,095,000 | -36.5% | 4,661,824 | 0.0% | 0.26% | -48.3% | |
| MEIP | MEI PHARMA INC | $11,001,000 | -18.6% | 4,400,440 | 0.0% | 0.25% | -33.9% | |
| AGRX | AGILE THERAPEUTICS INC | $10,443,000 | -17.9% | 8,426,750 | 0.0% | 0.24% | -33.1% | |
| FIAT CHRYSLER AUTOMOBILES N | $10,008,000 | +987.8% | 62,000 | 0.0% | 0.23% | +784.6% | ||
| ALEC | ALECTOR INC | $9,325,000 | -2.7% | 511,731 | 0.0% | 0.21% | -20.7% | |
| DXCM | New | DEXCOM INC | $8,990,000 | – | 60,000 | +100.0% | 0.21% | – |
| ANI PHARMACEUTICALS INCnote 3.000% 12/0 | $8,992,000 | +9.1% | 7,500,000 | 0.0% | 0.21% | -11.2% | ||
| AQUESTIVE THERAPEUTICS INC | $8,876,000 | -39.2% | 2,113,400 | 0.0% | 0.20% | -50.5% | ||
| ARWR | ARROWHEAD PHARMACEUTICALS INC | $8,765,000 | +44.4% | 330,738 | 0.0% | 0.20% | +17.5% | |
| ACOR | New | ACORDA THERAPEUTICS INC | $8,647,000 | – | 1,127,318 | +100.0% | 0.20% | – |
| SWAV | SHOCKWAVE MEDICAL INC | $8,564,000 | +70.6% | 150,000 | 0.0% | 0.20% | +38.7% | |
| MCRB | New | SERES THERAPEUTICS INC | $8,050,000 | – | 2,500,000 | +100.0% | 0.18% | – |
| SYBX | SYNLOGIC INC | $7,897,000 | +19.9% | 867,852 | 0.0% | 0.18% | -2.7% | |
| ICPT | New | INTERCEPT PHARMACEUTICALS INC | $7,766,000 | – | 97,600 | +100.0% | 0.18% | – |
| ORTX | ORCHARD THERAPEUTICS PLCads | $7,299,000 | -21.8% | 521,800 | 0.0% | 0.17% | -36.5% | |
| THC | New | TENET HEALTHCARE CORP | $6,211,000 | – | 300,633 | +100.0% | 0.14% | – |
| VCRA | Buy | VOCERA COMMUNICATIONS INC | $6,205,000 | +292.2% | 194,400 | +288.8% | 0.14% | +215.6% |
| RYTM | Sell | RHYTHM PHARMACEUTICALS INC | $5,785,000 | -58.0% | 262,970 | -47.7% | 0.13% | -65.8% |
| TBIO | TRANSLATE BIO INC | $5,494,000 | +23.9% | 435,000 | 0.0% | 0.13% | +0.8% | |
| RMTI | New | ROCKWELL MEDICAL INC | $4,515,000 | – | 1,500,000 | +100.0% | 0.10% | – |
| HSACU | New | HEALTH SCIENCES ACQUISITIONS CORPunit 04/01/2024 | $4,241,000 | – | 400,000 | +100.0% | 0.10% | – |
| TWST | New | TWIST BIOSCIENCE CORP | $3,216,000 | – | 110,856 | +100.0% | 0.07% | – |
| VERU | Buy | VERU INC | $3,078,000 | +47.9% | 1,445,000 | +1.4% | 0.07% | +20.3% |
| ACST | ACASTI PHARMA INCcl a new | $2,029,000 | +11.8% | 1,779,882 | 0.0% | 0.05% | -7.8% | |
| SRRA | SIERRA ONCOLOGY INC | $1,493,000 | -67.3% | 2,666,190 | 0.0% | 0.03% | -73.6% | |
| EIGR | EIGER BIOPHARMACEUTICALS INC | $1,482,000 | -24.2% | 139,890 | 0.0% | 0.03% | -38.2% | |
| CRY | CRYOLIFE INC | $1,497,000 | +2.6% | 50,000 | 0.0% | 0.03% | -17.1% | |
| AXSM | AXSOME THERAPEUTICS INC | $1,387,000 | +80.8% | 53,879 | 0.0% | 0.03% | +45.5% | |
| VYGR | New | VOYAGER THERAPEUTICS INC | $996,000 | – | 36,573 | +100.0% | 0.02% | – |
| RACE | FERRARI N.V. | $1,001,000 | +20.6% | 6,200 | 0.0% | 0.02% | 0.0% | |
| MDCO | New | MEDICINES CO | $712,000 | – | 19,532 | +100.0% | 0.02% | – |
| ABEOW | ABEONA THERAPEUTICS INC*w exp 12/24/201 | $620,000 | -67.5% | 659,636 | 0.0% | 0.01% | -74.1% | |
| GH | New | GUARDANT HEALTH INC | $571,000 | – | 6,617 | +100.0% | 0.01% | – |
| FLDM | FLUIDIGM CORP | $567,000 | -7.4% | 46,030 | 0.0% | 0.01% | -23.5% | |
| ZIOP | New | ZIOPHARM ONCOLOGY INC | $528,000 | – | 90,498 | +100.0% | 0.01% | – |
| ALNA | ALLENA PHARMACEUTICALS INC | $538,000 | -42.1% | 132,300 | 0.0% | 0.01% | -53.8% | |
| MREO | New | MEREO BIOPHARMA GROUP PLCads | $452,000 | – | 179,419 | +100.0% | 0.01% | – |
| New | CONFORMIS INC | $436,000 | – | 100,000 | +100.0% | 0.01% | – | |
| TNDM | Sell | TANDEM DIABETES CARE INC | $414,000 | -49.3% | 6,422 | -50.0% | 0.01% | -60.9% |
| NTRA | New | NATERA INC | $401,000 | – | 14,549 | +100.0% | 0.01% | – |
| XBI | New | SPDR SERIES TRUSTput | $70,000 | – | 200,000 | +100.0% | 0.00% | – |
| BIIB | Sell | BIOGEN INCcall | $65,000 | -89.5% | 200,000 | -50.0% | 0.00% | -94.1% |
| SLDB | New | SOLID BIOSCIENCES INCcall | $23,000 | – | 200 | +100.0% | 0.00% | – |
| OTLKW | OUTLOOK THERAPEUTICS INC*w exp 02/18/202 | $46,000 | -71.1% | 420,875 | 0.0% | 0.00% | -75.0% | |
| ONCS | Exit | ONCOSEC MEDICAL INC | $0 | – | -30,000 | -100.0% | 0.00% | – |
| IMGN | Exit | IMMUNOGEN INCcall | $0 | – | -600,000 | -100.0% | 0.00% | – |
| Exit | SOLID BIOSCIENCES INCcall | $0 | – | -10,000 | -100.0% | -0.00% | – | |
| ASND | Exit | ASCENDIS PHARMA A Sput | $0 | – | -200,000 | -100.0% | -0.00% | – |
| AGIO | Exit | AGIOS PHARMACEUTICALS INCcall | $0 | – | -200,000 | -100.0% | -0.00% | – |
| IMMU | Exit | IMMUNOMEDICS INCcall | $0 | – | -200,000 | -100.0% | -0.00% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INCcall | $0 | – | -200,000 | -100.0% | -0.00% | – |
| EOLS | Exit | EVOLUS INC | $0 | – | -15,232 | -100.0% | -0.01% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -14,897 | -100.0% | -0.01% | – |
| BEAT | Exit | BIOTELEMETRY INC | $0 | – | -6,369 | -100.0% | -0.01% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INCcall | $0 | – | -100,000 | -100.0% | -0.01% | – |
| FGEN | Exit | FIBROGEN INC | $0 | – | -9,306 | -100.0% | -0.01% | – |
| VCEL | Exit | VERICEL CORP | $0 | – | -28,090 | -100.0% | -0.01% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INCput | $0 | – | -200,000 | -100.0% | -0.02% | – |
| VCYT | Exit | VERACYTE INC | $0 | – | -31,521 | -100.0% | -0.02% | – |
| AVDR | Exit | AVEDRO INC | $0 | – | -100,000 | -100.0% | -0.04% | – |
| ABEO | Exit | ABEONA THERAPEUTICS INC | $0 | – | -180,797 | -100.0% | -0.04% | – |
| OMED | Exit | ONCOMED PHARMACEUTICALS INC | $0 | – | -1,719,111 | -100.0% | -0.05% | – |
| XENT | Exit | INTERSECT ENT INC | $0 | – | -70,000 | -100.0% | -0.06% | – |
| RARE | Exit | ULTRAGENYX PHARMACEUTICAL INC | $0 | – | -50,000 | -100.0% | -0.10% | – |
| LIVN | Exit | LIVANOVA PLC | $0 | – | -40,000 | -100.0% | -0.11% | – |
| HUM | Exit | HUMANA INC | $0 | – | -35,000 | -100.0% | -0.26% | – |
| PRQR | Exit | PROQR THERAPEUTICS N.V. | $0 | – | -722,523 | -100.0% | -0.28% | – |
| AKBA | Exit | AKEBIA THERAPEUTICS INC | $0 | – | -1,703,440 | -100.0% | -0.39% | – |
| IRTC | Exit | IRHYTHM TECHNOLOGIES INC | $0 | – | -200,000 | -100.0% | -0.42% | – |
| Exit | SOLID BIOSCIENCES INC | $0 | – | -3,927,222 | -100.0% | -1.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
About Perceptive Advisors
Perceptive Advisors is a New York-based hedge fund that specializes in healthcare investments. The company was founded in 1999 by Joseph Edelman, who serves as the CEO and Chief Investment Officer. Since its inception, Perceptive Advisors has become one of the most successful healthcare-focused hedge funds in the world, with over $5 billion in assets under management.
The company's investment strategy is based on a deep understanding of the healthcare industry and a focus on identifying promising companies with innovative products and technologies. Perceptive Advisors invests in a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
One of the key factors behind Perceptive Advisors' success is its team of experienced professionals. In addition to Joseph Edelman, the company's leadership team includes Adam Stone, the COO, and Jeremy Goldberg, the Chief Scientific Officer. The team also includes a group of highly skilled analysts and researchers who are experts in their respective fields.
Perceptive Advisors has a strong track record of generating high returns for its investors. However, it is important to note that investing in hedge funds carries significant risks, and investors should carefully consider their investment objectives and risk tolerance before investing. As with any investment, it is important to conduct thorough research and seek the advice of a qualified financial advisor before making any investment decisions.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES SHARES | 42 | Q3 2023 | 15.7% |
| AMICUS THERAPEUTICS SHARES | 39 | Q3 2023 | 14.0% |
| ALDEYRA THERAPEUTICS SHARES | 35 | Q3 2023 | 3.3% |
| QUOTIENT TECHNOLOGY INC | 34 | Q3 2022 | 2.7% |
| GLOBAL BLOOD THERAPEUTICS SHARES | 29 | Q3 2022 | 9.3% |
| ADMA BIOLOGICS SHARES | 29 | Q3 2023 | 1.4% |
| RETROPHIN SHARES | 28 | Q3 2020 | 5.5% |
| DBV TECHNOLOGIES SA-SPON ADR | 28 | Q3 2021 | 1.8% |
| VBI VACCINES SHARES | 27 | Q1 2023 | 2.8% |
| IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
View Perceptive Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CHEMBIO DIAGNOSTICS, INC.Sold out | May 04, 2023 | 0 | 0.0% |
| VBI Vaccines Inc/BC | April 07, 2023 | 43,509,553 | 16.7% |
| Landos Biopharma, Inc. | March 30, 2023 | 14,869,915 | 47.7% |
| REATA PHARMACEUTICALS INC | March 07, 2023 | 2,083,799 | 6.5% |
| AGILE THERAPEUTICS INCSold out | February 14, 2023 | 0 | 0.0% |
| ALBIREO PHARMA, INC. | February 14, 2023 | 1,757,160 | 8.5% |
| BELLUS Health Inc. | February 14, 2023 | 8,891,027 | 7.1% |
| CinCor Pharma, Inc. | February 14, 2023 | 2,576,325 | 5.9% |
| Coherus BioSciences, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| CONCERT PHARMACEUTICALS, INC. | February 14, 2023 | 1,800,000 | 3.6% |
View Perceptive Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-04-17 |
| 4 | 2024-04-15 |
| SC 13G/A | 2024-04-15 |
| SC 13G | 2024-04-15 |
| SC 13D/A | 2024-04-10 |
| 4 | 2024-04-08 |
| 4 | 2024-04-03 |
| SC 13D/A | 2024-04-03 |
| SC 13D | 2024-03-20 |
View Perceptive Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.